B7-H4 treatment of t cells inhibits erk, jnk, p38, and akt activation

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wang, Xiaojie ^a   Hao, Jianqiang ^a   Metzger, Daniel L ^a   Ao, Ziliang ^a   Chen, Lieping ^b   Ou, Dawei ^a   Verchere, C Bruce ^a   Mui, Alice ^a   Warnock, Garth L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD69 ANTIGEN; GLYCOGEN SYNTHASE KINASE 3; HYBRID PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; T LYMPHOCYTE RECEPTOR; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; VTCN1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MITOSIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL PROLIFERATION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, INBRED BALB C; ONCOGENE PROTEIN V-AKT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84855391229     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028232     Document Type: Article

References (40)

1. Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, et al. (2003) B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18: 849-861.
2. Prasad DV, Richards S, Mai XM, Dong C, (2003) B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18: 863-873.
3. Zang X, Loke P, Kim J, Murphy K, Waitz R, et al. (2003) B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci U S A 100: 10388-10392.
4. Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, et al. (2006) Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant 15: 399-410.
5. Wang X, Hao J, Metzger DL, Mui A, Ao Z, et al. (2009) Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation 87: 482-490.
6. Weiss A, Imboden JB, (1987) Cell surface molecules and early events involved in human T lymphocyte activation. Adv Immunol 41: 1-38.
7. Straus DB, Weiss A, (1992) Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593.
8. Irving BA, Chan AC, Weiss A, (1993) Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med 177: 1093-1103.
9. Kolanus W, Romeo C, Seed B, (1993) T cell activation by clustered tyrosine kinases. Cell 74: 171-183.
10. Whitehurst CE, Owaki H, Bruder JT, Rapp UR, Geppert TD, (1995) The MEK kinase activity of the catalytic domain of RAF-1 is regulated independently of Ras binding in T cells. J Biol Chem 270: 5594-5599.
11. Calvo CR, Amsen D, Kruisbeek AM, (1997) Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J Exp Med 186: 1645-1653.
12. Ziegler SF, Ramsdell F, Alderson MR, (1994) The activation antigen CD69. Stem Cells 12: 456-465.
13. Whitehurst CE, Geppert TD, (1996) MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J Immunol 156: 1020-1029.
14. Owaki H, Varma R, Gillis B, Bruder JT, Rapp UR, et al. (1993) Raf-1 is required for T cell IL2 production. EMBO J 12: 4367-4373.
15. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, et al. (1994) JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77: 727-736.
16. Su B, Karin M, (1996) Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8: 402-411.
17. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA, (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
18. Choi IH, Zhu G, Sica GL, Strome SE, Cheville JC, et al. (2003) Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 171: 4650-4654.
19. Yuan CL, Xu JF, Tong J, Yang H, He FR, et al. (2009) B7-H4 transfection prolongs beta-cell graft survival. Transpl Immunol 21: 143-149.
20. Tringler B, Zhuo S, Pilkington G, Torkko KC, Singh M, et al. (2005) B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 11: 1842-1848.
21. Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, et al. (2006) B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203: 871-881.
22. Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, et al. (2006) B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A 103: 10391-10396.
23. Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, et al. (2005) The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 306: 128-141.
24. Awadallah NS, Shroyer KR, Langer DA, Torkko KC, Chen YK, et al. (2008) Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Pancreas 36: 200-206.
25. Kryczek I, Wei S, Zou L, Zhu G, Mottram P, et al. (2006) Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 177: 40-44.
26. Toyooka K, Maruo S, Iwahori T, Yamamoto N, Tai XG, et al. (1996) CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism. Int Immunol 8: 159-169.
27. Schwartz RH, (1990) A cell culture model for T lymphocyte clonal anergy. Science 248: 1349-1356.
28. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, et al. (1995) CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98.
29. Meagher C, Tang Q, Fife BT, Bour-Jordan H, Wu J, et al. (2008) Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J Immunol 180: 7793-7803.
30. Honstettre A, Meghari S, Nunes JA, Lepidi H, Raoult D, et al. (2006) Role for the CD28 molecule in the control of Coxiella burnetii infection. Infect Immun 74: 1800-1808.
31. Parry RV, Reif K, Smith G, Sansom DM, Hemmings BA, et al. (1997) Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur J Immunol 27: 2495-2501.
32. Kane LP, Andres PG, Howland KC, Abbas AK, Weiss A, (2001) Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol 2: 37-44.
33. Jones RG, Elford AR, Parsons MJ, Wu L, Krawczyk CM, et al. (2002) CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med 196: 335-348.
34. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, et al. (1999) Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11: 281-288.
35. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN, (1997) Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci U S A 94: 3627-3632.
36. Kelly E, Won A, Refaeli Y, Van Parijs L, (2002) IL-2 and related cytokines can promote T cell survival by activating AKT. J Immunol 168: 597-603.
37. Veillette A, Bookman MA, Horak EM, Bolen JB, (1988) The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55: 301-308.
38. Karnitz L, Sutor SL, Torigoe T, Reed JC, Bell MP, et al. (1992) Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol Cell Biol 12: 4521-4530.
39. Chiang GG, Sefton BM, (2000) Phosphorylation of a Src kinase at the autophosphorylation site in the absence of Src kinase activity. J Biol Chem 275: 6055-6058.
40. Kong G, Dalton M, Bubeck Wardenburg J, Straus D, Kurosaki T, et al. (1996) Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol Cell Biol 16: 5026-5035.